Cabergoline plus Lanreotide for Ectopic Cushing's Syndrome

Abstract

n engl j med 352;23 www.nejm.org june 9, 2005 correspondence 2457 myocardial dysfunction developed in our patient after the administration of doxorubicin in a single dose well below that typically associated with car-diotoxic effects. The rapid improvement in left ven-tricular function observed in this patient within four weeks suggests that substantial myocardial stun-ning was present. Although it is very rare, acute re-versible left ventricular failure should be considered in patients in whom respiratory failure or shock de-velops after the administration of even a single dose of doxorubicin. 1. Roche A, Girish BV, de Baere T, et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 2003;13:136-40. 2. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy.